To warrant a sustained level of glycolysis, cancer cells maintain a low level of citrate for unrestrained PFK1 and PFK2 activity, the latter producing fructose 2,6-bisphosphate (F2,6BP), a powerful allosteric activator of PFK1 [3,4,5]. The gene discussed is PFKM; the disease is cancer.